G6PC2
Basic information
Region (hg38): 2:168901291-168910000
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the G6PC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 13 | 15 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 2 | 2 |
Variants in G6PC2
This is a list of pathogenic ClinVar variants found in the G6PC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-168901350-A-G | not specified | Uncertain significance (Jul 07, 2022) | ||
2-168901489-T-C | not specified | Uncertain significance (Aug 11, 2022) | ||
2-168902447-T-A | not specified | Uncertain significance (Jan 30, 2024) | ||
2-168904601-C-G | not specified | Uncertain significance (Nov 12, 2021) | ||
2-168904613-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
2-168906660-G-A | G6PC2-related disorder | Benign (May 28, 2019) | ||
2-168906692-T-C | not specified | Uncertain significance (May 21, 2024) | ||
2-168906712-T-G | not specified | Uncertain significance (Jan 03, 2024) | ||
2-168907579-G-T | not specified | Uncertain significance (Jan 31, 2022) | ||
2-168907638-G-A | G6PC2-related disorder | Likely benign (Apr 01, 2019) | ||
2-168907710-G-A | G6PC2-related disorder | Likely benign (Apr 02, 2019) | ||
2-168907858-C-T | Fasting plasma glucose level quantitative trait locus 1 | Uncertain significance (Mar 05, 2018) | ||
2-168907884-C-A | not specified | Uncertain significance (Jan 31, 2022) | ||
2-168907898-G-A | not specified | Uncertain significance (May 12, 2024) | ||
2-168907957-G-A | not specified | Uncertain significance (Jun 08, 2022) | ||
2-168907972-T-G | not specified | Uncertain significance (Nov 22, 2023) | ||
2-168907979-T-A | not specified | Uncertain significance (Jul 14, 2021) | ||
2-168907981-T-C | G6PC2-related disorder | Benign (Apr 01, 2019) | ||
2-168908036-C-G | G6PC2-related disorder | Benign (Oct 24, 2019) | ||
2-168908041-C-G | not specified | Uncertain significance (Dec 13, 2022) | ||
2-168908046-G-A | not specified | Uncertain significance (Mar 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
G6PC2 | protein_coding | protein_coding | ENST00000375363 | 5 | 8756 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.96e-16 | 0.00133 | 125242 | 2 | 504 | 125748 | 0.00201 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.237 | 194 | 185 | 1.05 | 0.00000937 | 2339 |
Missense in Polyphen | 61 | 56.01 | 1.0891 | 759 | ||
Synonymous | -1.84 | 90 | 70.4 | 1.28 | 0.00000393 | 689 |
Loss of Function | -1.09 | 21 | 16.2 | 1.29 | 8.57e-7 | 166 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00337 | 0.00337 |
Ashkenazi Jewish | 0.00377 | 0.00378 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.00279 | 0.00278 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.00101 | 0.00101 |
Other | 0.00326 | 0.00326 |
dbNSFP
Source:
- Function
- FUNCTION: May hydrolyze glucose-6-phosphate to glucose in the endoplasmic reticulum. May be responsible for glucose production through glycogenolysis and gluconeogenesis (By similarity). {ECO:0000250}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Adipocytokine signaling pathway - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Insulin resistance - Homo sapiens (human);Starch and sucrose metabolism - Homo sapiens (human);Carbohydrate digestion and absorption - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Amino Acid metabolism;PI3K-Akt Signaling Pathway;Metabolism of carbohydrates;glycogenolysis;Metabolism;gluconeogenesis;Gluconeogenesis;Glucose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.623
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.18
Haploinsufficiency Scores
- pHI
- 0.130
- hipred
- N
- hipred_score
- 0.250
- ghis
- 0.460
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.633
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- G6pc2
- Phenotype
- hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- gluconeogenesis;dephosphorylation;glucose homeostasis;regulation of insulin secretion;glucose 6-phosphate metabolic process
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- glucose-6-phosphatase activity